purchased from Abmart (Shanghai, China) and anti-PD-1(E-18) antibody was purchased from Santa Cruz, Inc (USA). Anti-MMP2 antibody was purchased from Abcam (Cambridge, UK). Anti-PD-L1 antibody was purchased from Novus (Littleton, USA). Anti-rabbit IgG and Cy3-labeled goat antibody was purchased from Boster (Wuhan, China). Anti-mouse IgG and Cy3-labeled goat antibody was purchased from Abcam (Cambridge, UK). Goat anti-mouse peroxidase-coupled antibody and rabbit anti-goat peroxidase-coupled antibody were purchased from Thermo (Waltham, USA). The plasmid pET30a(+)/dFv-LDP carrying the gene of dFv (anti-gelatinases) was provided by Prof. Yongsu Zhen from
Chinese Academy of Medical Sciences and Peking Union Medical
College. E.coli DH5α was preserved in our laboratory and E.coli Transetta (DE3) was purchased from TransGen Biotech Co., Ltd. (Beijing, China).
Construction of plasmid pET-30a (+)/dFv-ePD1.
Mouse spleen cells were isolated from C57BL/6 mice under aseptic conditions using mouse splenic lymphocyte separation solution (Dakewe, Beijing, China) . Subsequently, the spleen cells were harvested and total RNA was extracted from the splenic cells using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, USA), according to the manufacturer's instructions. The RNA samples were then reverse transcribed into cDNA using a PrimeScript RT Reagent kit (Thermo, Waltham, USA). The cDNA was used as the template for polymerase chain reaction (PCR) analysis. The extracellular coding sequence of PD-1 (ePD1) was amplified from the cDNA template using a pair of primers: P1, forward 5'-TCGACAAGCTTGGTGGAGGCGGTTCAATGTGGGTCCGGCAG GTACCCTGG-3' and P2, reverse 5'-CGCACTCGAGTTGAAACCGGCCTTCTGGTTTGGGCGAGGGG CTGGGATA-3'. The restriction recognition sites of HindⅢ and XhoI were introduced into the 5' ends of P1 and P2, respectively. PCR was performed as follows: 94˚C for 5 min, 94˚C for 30 sec, 61˚C for 30 sec and 72˚C for 1 min, then held at 72˚C for 5 min, and finally a 4˚C standby.
Subsequently, the PCR product ePD1 and plasmid pET30a(+)/dFv-LDP were double-digested with restriction enzymes HindⅢ and XhoI, respectively, and then mixed the two digested products followed by ligating at 16˚C overnight to generate the recombinant plasmid pET-30a(+)/dFv-ePD1. Finally, DNA sequencing analysis was carried out to verify the correct insertion of the dFv-ePD1 gene.
Preparation of fusion protein dFv-ePD1
E.coli Transetta (DE3) transformed with pET30a(+)/dFv-ePD1 was 
Identification of fusion protein dFv-ePD1
The proteins were analyzed using SDS-PAGE and Western blotting .
Equal amounts of protein samples were separated on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel followed by electrotransfer to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked with 5% skim milk for 2 h, incubated with respective primary antibody (anti-His-Tag antibody, 1/4000 dilution, and PD-1 antibody 1/3000 dilution) at 4˚C overnight, and then incubated with appropriate secondary antibodies (1/5000 dilution).
Protein bands were visualized using a chemiluminescent HRP substrate kit (Millipore, Temecula, USA).
Reverse Zymography
The inhibition of fusion protein dFv-ePD1 to gelatinase was analyzed using reverse Zymography. MCF-7 cells were seeded in a cell culture dish and maintained in exponential growth to 90% confluence. After washed gently with serum-free DMEM medium thrice, the cells were incubated for 24 h with serum-free DMEM medium. The medium was harvested and centrifuged at 1000 rpm to remove cellular debris. Then 30μl of medium was mixed with different concentration of proteins (dFv-ePD1 and dFv) and 5× sample buffer (1 mol/L Tris-HCl, pH 6.8, 50% glycerol, 0.1% bromophenol blue). Samples were subjected to non-denaturing polyacrylamide gel through 10% polyacrylamide gels containing 0.1% gelatin. Gels were rinsed in washing buffer (50 mM Tris-HCl, pH 7.6, 2.5% Triton X-100) at room temperature for 1 hour and incubated in incubation buffer (50 mM Tris-HCl, pH 7.6, 10 mM CaCl 2 , and 150 mM NaCl) at 37˚C overnight. Gels were fixed in 25% isopropanol and 10% acetic acid and stained with 0. 
Flow cytometry
The B16-F1 cells were digested with trypsin and fixed with 80% ethanol for 30 min at 4˚C. Than the B16-F1 cell suspensions were blocked with 1% goat serum for 2 h at 37˚C. After washed with PBS, the cells were incubated with 0.2 mg/mL dFv-ePD1 and Anti-MMP2 antibody (1:100) at 37˚C for 4 h. The cells were then incubated with mouse anti-His-Tag mAb and Cy3-conjugated goat anti-mouse antibody. Isotype matched antibody was used as control. Samples were analyzed on a LSR-II flow cytometer.
Immunohistochemistry.
Human paraffin embedded melanoma tissue microarray (ME482a, Alenabio, China), including 24 cases of melanoma and 24 normal skin tissues, was baked for 60 minutes at 60˚C in a dehydration oven and heat-induced epitope was retrieved in the boiling pressure cooker for 3 minutes and then cooled to room temperature in PBS for 5 minutes.
Non-specific binding was blocked with 5% BSA in PBS. Next, the array was incubated with dFv-ePD1 in a humid chamber at 4˚C overnight.
anti-His-Tag mAb (diluted 1:1000) was used as the primary antibody.
After three times of PBST washing, array was incubated with horseradish peroxidase conjugated secondary antibodies for 20 min, followed by staining using diaminobenzidine (DAB) substrate. Then the array was counterstained with hematoxylin. Finally, the photographic image results of the entire tissue of each case of the melanoma tissue microarray were captured under the same illumination condition and magnification. Then, the cumulative optical density value (Integrated Optical Density, IOD) of each image was calculated by Image-Pro Plus 6.0 software. And the mean cumulative optical density of melanoma tissues and normal skin tissues were analyzed statistically.
MTT assay.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine cell proliferation. Cells were seeded in 96-well plates at a density of 3000 cells/well, incubated in 37˚C for 24 h and then exposed to different agents for 24 h, 48 h and 72 h. MTT (Sigma, St. Louis, Missouri, America) solution (5 mg/mL) was added to each well and incubated for another 4 h at 37˚C. The supernatant was removed and 150 µl DMSO were added to each well. The absorbance at 570 nm was measured by a microplate reader. Growth inhibition was calculated as times of controls in 0 h.
Cell migration and invasion assay.
The migration and invasion of cells was measured using transwell inserts and dFv for 48 h respectively, the cells in the upper chamber were removed with a cotton swab while other cells, which had passed through the filter on the underside of the membrane, were fixed with methanol, stained with 0.01% crystal violet and then captured by the camera on invert microscope. Subsequently, the crystal violet was then dissolved with 33% acetic acid and the absorbance was measured at 540 nm by using a microplate reader. 
In vivo imaging of fluorescein-labeled proteins

In vivo therapeutic efficacy
Animal experiments were conducted using 6-8 weeks male C57BL/6 mice, which were purchased from the Experimental Animal Center, Three
Gorges University (Yichang, China). The melanoma B16- Tumor volumes were measured every days with a caliper.
Statistical analysis.
Significant differences between two groups were determined with Student's t-test. p < 0.05 was considered as statistically significant, and p < 0.01 was thought as highly significant.
